Sutro Biopharma Inc (STRO)
4.29
+0.04
(+1.06%)
USD |
NASDAQ |
May 08, 16:00
4.29
0.00 (0.00%)
After-Hours: 18:11
Sutro Biopharma Cash from Investing (Quarterly): -23.51M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.51M |
| September 30, 2023 | -114.02M |
| June 30, 2023 | 66.16M |
| March 31, 2023 | 67.45M |
| December 31, 2022 | -37.88M |
| September 30, 2022 | -78.04M |
| June 30, 2022 | 47.92M |
| March 31, 2022 | 32.98M |
| December 31, 2021 | 20.78M |
| September 30, 2021 | -2.242M |
| June 30, 2021 | 5.876M |
| March 31, 2021 | -121.73M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.81M |
| September 30, 2020 | 0.296M |
| June 30, 2020 | -57.14M |
| March 31, 2020 | 41.64M |
| December 31, 2019 | 7.942M |
| September 30, 2019 | 9.812M |
| June 30, 2019 | 9.194M |
| March 31, 2019 | -78.08M |
| December 31, 2018 | 2.025M |
| September 30, 2018 | -81.82M |
| June 30, 2018 | -0.036M |
| March 31, 2018 | -0.364M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-121.73M
Minimum
Mar 2021
67.45M
Maximum
Mar 2023
-5.722M
Average
7.942M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| AnaptysBio Inc | 49.18M |
| ABVC BioPharma Inc | 0.1542M |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 0.038M |
| Journey Medical Corp | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 14.07M |
| Cash from Financing (Quarterly) | -3.125M |
| Free Cash Flow | -115.93M |
| Free Cash Flow Per Share (Quarterly) | 0.2072 |
| Free Cash Flow to Equity (Quarterly) | 15.71M |
| Free Cash Flow to Firm (Quarterly) | 15.40M |
| Free Cash Flow Yield | -44.92% |